Calaguan, Rhandy Jr P.

HRN: 26-84-30  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
CEFUROXIME 1.5GM (VIAL)
03/20/2025
03/20/2025
IV
1.5
OCTOR
Inguinal Hernia, Left
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Urinary TractSkin & Soft TissueIntra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: